FAST, SECURE and VERY DISCREET
FREE GIFT, ANY ORDER, USE COUPON CODE 'GIFT23' ALL CAPS
|
|
| NewPlex HOME | LINKS TO OTHER SITES |
FAST, SECURE and VERY DISCREET |
|
ENHANCE FEMALE AROUSAL
VIGEL is a nonprescription, topical gel that is applied directly to the clitoral area and dramatically increases feminine sexual arousal.
VIGEL contains special ingredients such as Menthol and the amino acid L-Arginine. The Menthol instantly creates a delightful tingling sensation. The L-Arginine dramatically enhances circulation.
The 1998 Nobel Prize for Medicine and Physiology was awarded for the discovery of the Nitric Oxide Pathway. Nitric Oxide is the basis for clitoral erection and excitement. L-Arginine causes the production of Nitric Oxide which in turn improves clitoral circulation and thus leads to increased physical pleasure even for those women who have already experienced a loss of sexual desire.
Recent double-blind, placebo-controlled, clinical studies suggest that L-Arginine dramatically improves female sex drive and sexual relations, frequency of orgasms and clitoral sensitivity to stimulation.
VIGEL is a sterile, pharmaceutical grade product manufactured to the strictest specifications and is guaranteed to improve your sex-life or your money back! Whether you are multi-orgasmic or have trouble achieving climax, VIGEL will enhance your sexual experience more than you ever dreamed possible.
SCIENTIFIC EVIDENCE
VIGEL has received rave reviews from women who have no sexual dysfunction but appreciate the product nonetheless because it helps them have more intense and frequent orgasms. However, the L-Arginine in VIGEL has demonstrated its true strength in the following double blind studies conducted on post-menopausal and sexually dysfunctional women.
SUMMARIES OF CLINICAL TRIALS
One study on L-Arginine was conducted on post-menopausal women with Female Sexual Arousal Disorder or FSAD. The study was designed to determine the effects on vaginal blood flow and sexual arousal of the Nitric Oxide-precursor L-Arginine (as well as other substances) on physiological responses to erotic stimuli in post-menopausal women who had experienced FSAD for at least six months.
The study was a randomized, double-blind, placebo-controlled, three-way crossover clinical trial. Patients were 23 post-menopausal women who met DSM IV criteria for FSAD. The physiological sexual arousal of the subjects was measured by changes in vaginal pulse amplitude using a method called Vaginal Photoplethysmography.
The subjects were shown a neutral (non-sexual movie) as well as a film with sexual content. The degree of each subject's sexual reaction to the neutral as well as to the sexual movie was measured by the Vaginal Photoplethysmography technology. Subjective sexual arousal was also gauged by using a Self-Report Questionnaire that was standardized for all woman involved in the trial.
The results of the Vaginal Photoplethysmography showed a rapid and significant increase in Vaginal Pulse Amplitude Response (meaning the subject's degree of sexual stimulation) to the erotic film after the L-Arginine was administered as compared to the placebo group. The Self-Report Questionnaire yielded similar results. The study theorized that the mechanism responsible for the increase in sexual arousal was the body's enhanced production of Nitric Oxide due to the administration of L-Arginine.
The increased Nitric Oxide release caused the women who were given L-Arginine to be significantly more stimulated by the erotic content of the sexual film as opposed to those subjects who received the placebo.
The results of another clinical study of L-Arginine were presented at the Ninth Annual Congress on Women's Health & Gender-Based Medicine in Washington, D.C. The study indicated significant improvement in women's sexual desire and overall satisfaction. In this double-blind placebo-controlled study, 93 women, ages 22-73, enrolled as participants lacking sexual desire.
Of the 93 women involved, 46 received L-Arginine and 47 received a placebo. The participants used a Female Sexual Function Index Questionnaire to rate their level of sexual health before starting the study and after taking either a placebo or the L-Arginine.
At the end of four weeks, 62 percent of the active group reported significantly improved satisfaction with their overall sex life and 64 percent reported an improvement in their level of sexual desire.
TESTIMONIALS
Here is what women who have used VIGEL have told us about our product:
"Wow, your product really works! My husband and I were only having sex once a month at most. Now since I started using VIGEL, we're making love almost every day! Thank you, thank you, thank you!" --A.E., New York
"VIGEL is great. I've never found a product that makes sex so fulfilling. It's magic!" --L.B., Dallas "
I've always enjoyed sex with my boyfriend. But with VIGEL I enjoy it even more. Thanks to VIGEL, sex now is hotter, wetter and filled with more orgasms."-- S.P., Los Angeles, CA
"I can't believe how aroused it made me. Sex is so hot on VIGEL!" --S.S., Tarzana, CA "
Your product VIGEL exceeded my expectations! I've always had trouble reaching climax but VIGEL makes it easy."--L.S., Las Vegas
All models are at least 18 years of age